Indoor Particulate Matter Associated with Systemic Inflammation in COPD

DOI: 10.4236/jep.2015.65051   PDF   HTML   XML   3,444 Downloads   4,287 Views   Citations


Chronic obstructive pulmonary disease (COPD) is a chronic disease characterized by progressive airflow obstruction, along with pulmonary and systemic inflammation. Outdoor PM has been associated with morbidity and mortality in COPD but less is known about effects of indoor air quality. In former smokers with COPD, we investigated in-home PM effects on pulmonary and systemic inflammation, symptoms, and lung function. Participants underwent in-home air monitoring for two weeks and simultaneous health assessments. Median (IQR) PM2.5 was 9 (7) μg/m3. Increased indoor PM2.5 was associated with increased white blood cells, predominantly neutrophils and lymphocytes, suggesting that even relatively low indoor PM2.5 may elicit a systemic inflammatory response in COPD.

Share and Cite:

Bose, S. , Hansel, N. , Tonorezos, E. , Williams, D. , Bilderback, A. , Breysse, P. , Diette, G. and McCormack, M. (2015) Indoor Particulate Matter Associated with Systemic Inflammation in COPD. Journal of Environmental Protection, 6, 566-572. doi: 10.4236/jep.2015.65051.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Hogg, J.C. (2006) Why Does Airway Inflammation Persist after the Smoking Stops? Thorax, 61, 96-97.
[2] Willemse, B.W., ten Hacken, N.H., Rutgers, B., Lesman-Leegte, I.G., Postma, D.S. and Timens, W. (2005) Effect of 1-Year Smoking Cessation on Airway Inflammation in COPD and Asymptomatic Smokers. European Respiratory Journal, 26, 835-845.
[3] (2012) Chronic Respiratory Diseases; Burden of COPD. World Health Organization.
[4] Minino, A. (2011) Death in the United States, 2009. NCHS Data Brief, 64, 1-8.
[5] Dominici, F., Peng, R.D., Bell, M.L., Pham, L., McDermott, A., Zeger, S.L. and Samet, J.M. (2006) Fine Particulate Air Pollution and Hospital Admission for Cardiovascular and Respiratory Diseases. JAMA, 295, 1127-1134.
[6] Peacock, J.L., Anderson, H.R., Bremner, S.A., Marston, L., Seemungal, T.A., Strachan, D.P. and Wedzicha, J.A. (2011) Outdoor Air Pollution and Respiratory Health in Patients with COPD. Thorax, 66, 591-596.
[7] Atkinson, R.W., Anderson, H.R., Sunyer, J., Ayres, J., Baccini, M., Vonk, J.M., Boumghar, A., Forastiere, F., Forsberg, B., Touloumi, G., Schwartz, J. and Katsouyanni, K. (2001) Acute Effects of Particulate Air Pollution on Respiratory Admissions: Results from APHEA 2 Project. Air Pollution and Health: A European Approach. American Journal of Respiratory and Critical Care Medicine, 164, 1860-1866.
[8] Zhu, R., Chen, Y., Wu, S., Deng, F., Liu, Y. and Yao, W. (2013) The Relationship between Particulate Matter (PM10) and Hospitalizations and Mortality of Chronic Obstructive Pulmonary Disease: A Meta-Analysis. COPD, 10, 307-315.
[9] Ko, F.W. and Hui, D.S. (2012) Air Pollution and Chronic Obstructive Pulmonary Disease. Respirology, 17, 395-401.
[10] Klepeis, N.E., Nelson, W.C., Ott, W.R., Robinson, J.P., Tsang, A.M., Switzer, P., Behar, J.V., Hern, S.C. and Engelmann, W.H. (2001) The National Human Activity Pattern Survey (NHAPS): A Resource for Assessing Exposure to Environmental Pollutants. Journal of Exposure Analysis and Environmental Epidemiology, 11, 231-252.
[11] Leech, J.A. and Smith-Doiron, M. (2006) Exposure Time and Place: Do COPD Patients Differ from the General Population? Journal of Exposure Science and Environmental Epidemiology, 16, 238-241.
[12] Osman, L.M., Douglas, J.G., Garden, C., Reglitz, K., Lyon, J., Gordon, S. and Ayres, J.G. (2007) Indoor Air Quality in Homes of Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 176, 465-472.
[13] Hansel, N.N., McCormack, M.C., Belli, A.J., Matsui, E.C., Peng, R.D., Aloe, C., Paulin, L., Williams, D.L., Diette, G.B. and Breysse, P.N. (2013) In-Home Air Pollution Is Linked to Respiratory Morbidity in Former Smokers with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 187, 1085-1090.
[14] Hammond, S.K. and Leaderer, B.P. (1987) A Diffusion Monitor to Measure Exposure to Passive Smoking. Environmental Science Technology, 21, 494-497.
[15] Apelberg, B.J., Hepp, L.M., Avila-Tang, E., Gundel, L., Hammond, S.K., Hovell, M.F., Hyland, A., Klepeis, N.E., Madsen, C.C., Navas-Acien, A., Repace, J., Samet, J.M. and Breysse, P.N. (2013) Environmental Monitoring of Secondhand Smoke Exposure. Tobacco Control, 22, 147-155.
[16] Miller, M.R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Crapo, R., Enright, P., van der Grinten, C.P., Gustafsson, P., Jensen, R., Johnson, D.C., MacIntyre, N., McKay, R., Navajas, D., Pedersen, O.F., Pellegrino, R., Viegi, G. and Wanger. J. (2005) Standardisation of Spirometry. European Respiratory Journal, 26, 319-338.
[17] Hankinson, J.L., Odencrantz, J.R. and Fedan, K.B. (1999) Spirometric Reference Values from a Sample of the General U.S. Population. American Journal of Respiratory and Critical Care Medicine, 159, 179-187.
[18] Jones, P.W., Quirk, F.H. and Baveystock, C.M. (1991) St George’s Respiratory Questionnaire. Respiratory Medicine, 85, 25-31.
[19] Leidy, N.K., Rennard, S.I., Schmier, J., Jones, M.K. and Goldman, M. (2003) The Breathlessness, Cough, and Sputum Scale: The Development of Empirically Based Guidelines for Interpretation. Chest, 124, 2182-2191.
[20] American Thoracic Society and European Respiratory Society (2005) ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide. American Journal of Respiratory and Critical Care Medicine, 171, 912-930.
[21] Zeger, S.L. and Liang, K.Y. (1986) Longitudinal Data Analysis for Discrete and Continuous Outcomes. Biometrics, 42, 121-130.
[22] Leaderer, B.P. and Hammond, S.K. (1991) Evaluation of Vapour-Phase Nicotine and Respirable Suspended Particle Mass as Markers for Environmental Tobacco Smoke. Environmental Science Technology, 25, 770-777.
[23] Barnes, P.J. and Celli, B.R. (2009) Systemic Manifestations and Comorbidities of COPD. European Respiratory Journal, 33, 1165-1185.
[24] Agusti, A.G.N., Noguera, A., Sauleda, J., Sala, E., Pons, J. and Busquets, X. (2003) Systemic Effects of Chronic Obstructive Pulmonary Disease. European Respiratory Journal, 21, 347-360.
[25] Hajat, A., Allison, M., Diez-Roux, A.V., Jenny, N.S., Jorgensen, N.W., Szpiro, A.A., Vedal, S. and Kaufman, J.D. (2015) Long-Term Exposure to Air Pollution and Markers of Inflammation, Coagulation, and Endothelial Activation: A Repeat-Measures Analysis in the Multi-Ethnic Study of Atherosclerosis (MESA). Epidemiology, 26, 310-320.
[26] Hoffmann, B., Moebus, S., Dragano, N., Stang, A., Mohlenkamp, S., Schmermund, A., Memmesheimer, M., Brocker-Preuss, M., Mann, K., Erbel, R. and Jockel, K.H. (2009) Chronic Residential Exposure to Particulate Matter Air Pollution and Systemic Inflammatory Markers. Environmental Health Perspectives, 117, 1302-1308.
[27] Adar, S.D., D’Souza, J., Mendelsohn-Victor, K., Jacobs Jr., D.R., Cushman, M., Sheppard, L., Thorne, P.S., Burke, G.L., Daviglus, M., Szpiro, A.A., Diez Roux, A.V., Kaufman, J.D. and Larson, T.V. (2015) Markers of Inflammation and Coagulation after Long-Term Exposure to Coarse Particulate Matter: A Cross-Sectional Analysis from the Multi-Ethnic Study of Atherosclerosis. Environmental Health Perspectives, in Press.
[28] van Eeden, S.F., Yeung, A., Quinlam, K. and Hogg, J.C. (2005) Systemic Response to Ambient Particulate Matter: Relevance to Chronic Obstructive Pulmonary Disease. Proceedings of the American Thoracic Society, 2, 61-67.
[29] van Eeden, S.F., Tan, W.C., Suwa, T., Mukae, H., Terashima, T., Fujii, T., Qui, D., Vincent, R. and Hogg, J.C. (2001) Cytokines Involved in the Systemic Inflammatory Response Induced by Exposure to Particulate Matter Air Pollutants (PM(10)). American Journal of Respiratory and Critical Care Medicine, 164, 826-830.
[30] Brito, J.M., Macchione, M., Yoshizaki, K., Toledo-Arruda, A.C., Saraiva-Romanholo, B.M., Andrade Mde, F., Mauad, T., Rivero, D.H. and Saldiva, P.H. (1985) Acute Cardiopulmonary Effects Induced by the Inhalation of Concentrated Ambient Particles during Seasonal Variation in the City of Sao Paulo. Journal of Applied Physiology, 117, 492-499.
[31] Clarke, R.W., Coull, B., Reinisch, U., Catalano, P., Killingsworth, C.R., Koutrakis, P., Kavouras, I., Murthy, G.G., Lawrence, J., Lovett, E., Wolfson, J.M., Verrier, R.L. and Godleski, J.J. (2000) Inhaled Concentrated Ambient Particles Are Associated with Hematologic and Bronchoalveolar Lavage Changes in Canines. Environmental Health Perspectives, 108, 1179-1187.
[32] Riediker, M., Cascio, W.E., Griggs, T.R., Herbst, M.C., Bromberg, P.A., Neas, L., Williams, R.W. and Devlin, R.B. (2004) Particulate Matter Exposure in Cars Is Associated with Cardiovascular Effects in Healthy Young Men. American Journal of Respiratory and Critical Care Medicine, 169, 934-940.
[33] Seaton, A., Soutar, A., Crawford, V., Elton, R., McNerlan, S., Cherrie, J., Watt, M., Agius, R. and Stout, R. (1999) Particulate Air Pollution and the Blood. Thorax, 54, 1027-1032.
[34] Vestbo, J., Hurd, S.S., Agusti, A.G., Jones, P.W., Vogelmeier, C., Anzueto, A., Barnes, P.J., Fabbri, L.M., Martinez, F.J., Nishimura, M., Stockley, R.A., Sin, D.D. and Rodriguez-Roisin, R. (2013) Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary. American Journal of Respiratory and Critical Care Medicine, 187, 347-365.
[35] Eisner, M.D., Anthonisen, N., Coultas, D., Kuenzli, N., Perez-Padilla, R., Postma, D., Romieu, I., Silverman, E.K., Balmes, J.R. (2010) Committee on Nonsmoking COPD, Environmental and Occupational Health Assembly. An Official American Thoracic Society Public Policy Statement: Novel Risk Factors and the Global Burden of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 182, 693-718.
[36] Osman, L.M., Douglas, J.G., Garden, C., Reglitz, K., Lyon, J., Gordon, S., Ayres, J.G. (2007) Indoor Air Quality in Homes of Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 176, 465-472.

comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.